Development of inCVAX, In situ Cancer Vaccine, and Its Immune Response in Mice with Hepatocellular Cancer

Manipulation of immune system toward the rejection of established cancers has become the standard of care in some patients. Here we propose the development of an in situ autologous cancer vaccine, inCVAX, for the treatment of hepatocellular cancer (HCC). inCVAX is based on the induction of local imm...

Descripción completa

Detalles Bibliográficos
Autores principales: Qi, Xiaoqiang, Lam, Samuel SK, Liu, Dai, Kim, Dae Young, Ma, Lixin, Alleruzzo, Lu, Chen, Wei, Hode, Tomas, Henry, Carolyn J, Kaifi, Jussuf, Kimchi, Eric T, Li, Guangfu, Staveley-O’Carroll, Kevin F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5027967/
https://www.ncbi.nlm.nih.gov/pubmed/27656328
http://dx.doi.org/10.4172/2155-9899.1000438

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5027967/
https://www.ncbi.nlm.nih.gov/pubmed/27656328
http://dx.doi.org/10.4172/2155-9899.1000438

Ejemplares similares